Diabetic Nephropathy: Test and Diagnosis

1st order laboratory parameters – obligatory laboratory tests.

Bold: control parameters that should be checked at least twice a year.* Additional laboratory parameters from CKD stage 3 (creatinine clearance < 60 ml/min/1.73 m 2).

In urine testing, attention is paid primarily to the presence of protein (albumin) or albumin (due to kidney damage).

A distinction is made between

  • Microalbuminuria – in this case, between 20-200 mg / l albumin (a special protein) is present in the urine.
  • Macroalbuminuria – this is more than 200 mg / l albumin in the urine.

Since the albumin value can also be temporarily increased, for example, during physical exertion or febrile illness, a conspicuous value should always be checked.

Laboratory parameters 2nd order – depending on the results of the history, physical examination, etc. – for differential diagnostic clarification.

Screening of diabetic nephropathy (DN)

Screening for DN in all people with type 2 diabetes and in all type 1 diabetic patients from 5 years after diagnosis consists of:

  • Serum creatinine-based GFR (eGFR) estimation by CKD-EPI formula (CKD-EPI: “Chronic Kidney Disease Epidemiology Collaboration”)/cystatin C would be better.
  • Urinary albumin excretion (Note: microalbuminuria is not specific for diabetic nephropathy and also shows high variability).
  • Urine proteomic analysis by capillary electrophoresis and mass spectrometry (CE-MS) – CKD273 maps insb. fibrosis (e.g., via collagens) and inflammation (e.g., via α-1-antitrypsin); this urine proteome classifier is already used for early detection of “chronic kidney disease” (CKD).